ICH Q3D Elemental impurities

This document presents a process to assess and control elemental impurities in the drug product using the principles of risk management as described in ICH Q9. This process provides a platform for developing a risk-based control strategy to limit elemental impurities in the drug product.

Please note that new/revised guideline sections are to be included in the Revision 2 of the guideline (see further down).

Keywords: Elemental impurities, limit, safety, routes of administration, toxicity, permitted daily exposure (PDE), risk assessment, control, specification, analytical

Document history

Superseded documents

Topics

How useful was this page?

Add your rating
Average
4 ratings
1 rating
4 ratings